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Since the discovery by Netter (1) and Levaditi (2) of the presence of 
virus-neutralizing antibodies in the blood, both from human convales- 
cents  and  from monkeys recovered from  experimental poliomyelitis, 
several attempts have been made to immunize large animals with a 
view to quantity production of therapeutic serum. 
The results of Aycock (3) and others who have used convalescent serum in the 
treatment of poliomyelitis tend to indicate that serum therapy is effective when 
used in the preparalytic stage of this disease.  The difficulties  encountered in 
obtaining ample quantities of human immune serum have hampered its wide- 
spread use. 
Flexner (4), in 1910, reported unsuccessful attempts to bring forth an immuno- 
logical response in a horse by injection over a period of many months of filtrates 
carrying the active virus of poliomyelitis. 
In 1917, Banzhaf and Neustaedter (5) published the results of similar efforts, 
having injected subcutaneously and intramuscularly the supernatant fluid from 
emulsions  of brains and spinal cords of monkeys dying of poliomyelitis.  This 
antiserum gave some evidence of ability to neutralize virus in the few experiments 
then conducted. 
Pettit (6), in 1918 described the preparation and subsequent use in human eases 
of a horse serum drawn from an animal which had received  injections over a period 
of 2 years.  He did not test this serum directly for virus-neutralizing antibodies 
but depended upon clinical results for an index of its usefulness.  Later, Stewart 
and Haselbauer (7) investigated this preparation and found it to neutralize virus 
* The expenses  of this experimental study were largely defrayed by a gift of 
money to New York University by Mr. Jeremiah Milbank, this University being 
one of the group working  under the International Committee for the Study of 
Infantile Paralysis. 
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only occasionally and then only in a ratio of 1 part of virus emulsion to 3 parts of 
serum.  These workers also attempted without success  to produce an antiserum 
from sheep.  At the same time they also tested Rosenow's antistreptococcus serum 
of alleged therapeutic value in poliomyelitis and found it to be devoid of any 
virucidal principles. 
Herein  is  reported  the  successful  production  of  potent  virus- 
neutralizing preparations drawn from immunized horses with evidence 
relative to its potency from the standpoint  of prophylaxis and thera- 
peutics. 
Method 
In general it has been found satisfactory to inject horses with virulent cord 
emulsion (10 per cent) in doses increasing from 1 cc. to 50 cc.  The inoculations are 
given subcutaneously or intradermally and are administered on 4 successive days 
in each week.  That certain horses fail to respond has been demonstrated.  It has 
also been found that horses having no measurable native antibody may readily 
become producers of a high titre serum.  Indeed, in no horse has there yet been 
found evidence of a specific antibody prior to the immunization treatments. 
After 2 months of injections, horses which will satisfactorily respond to the 
immunization will have produced sufficient antibody to neutralize the active virus 
of poliomyelitis.  Evidence of worth is determined by means of an in vitro neutrali- 
zation test, the technique of which is as follows: 
5 per cent virus emulsions are prepared by grinding virulent monkey spinal cord 
with saline.  The serums to be tested are added in the desired proportion and after 
an hour's incubation at room temperature the mixtures are introduced into the 
cerebral hemispheres of susceptible monkeys.  The  amount of inoculum is so 
calculated that it represents at least two infective doses.  The potency of the virus 
has apparently no effect upon the amount of a specified serum preparation needed 
to neutralize it.  When using particularly potent strains of virus the inoculum 
often contains as many as several hundred k~lling doses of virus. 
Using  this  procedure  it  has  been  possible  to  determine  several 
relative  values  quite  accurately.  For  example,  pooled  convalescent 
serum  from  human  poliomyelitis  cases  will  consistently  neutralize 
5 per cent virus emulsion in the ratio of 1 part of serum to 20 parts of 
virus but fails to do so when the ratio is 1: 30.  This has been demon- 
strated by the titration of two pools of convalescent serum each con- 
taining serum from sixteen individuals. 
Individual  serums  from so-called  normal  human  adults  will  often E. R. WEYER~  W. H. PARK,  AND  E..T.  BANZHAF 
TABLE  I 
Virueidal Properties of Various Human Sera 
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Serum tested 
Human convalescent serum pooled 
~28  D.3  226  A 
220  3.3  226  " 
227  3.3  226  " 
H4  3.3  89  B 
"Normal" adult serum 
294  3.4  267  Donor 1 
D3  3.4  267  "  1 
310  3.4  298  "  2 
309  D.4  298  "  3 
305  3.4  298  "  4 
t62  3.4  457  "  5 
~,66  3.8  10  "  5 
i  4  384  i0.  457  "  6 
i 
167  10.8  10  "  6 
385  0.4  457  "  7 
158  0.4  457  "  8 
168  0.4  10  "  9 
311  0.3  298  Control, no serum 
312  0.1~  298  "  "  " 
~79  0.3  267  "  "  " 
~82  0.15  267  "  "  " 
U5  0.3  10  "  "  " 
~58  0.15  10  "  "  " 
t60  0.3  457  "  "  " 
161  0.15  457  "  "  " 
H0  0.5  89  "  "  " 
.~31  0.3  226  "  "  " 
.t52  0.3  248  "  "  " 
.~61  0.1~  248  "  "  " 
H5  0.5  89  Virus emulsion q- saline -t- tdcresol 
O~  iI~t  ~ 
days 
10:1 
20:1 
40:1  7 
20:1 .... 
i0:I 
20:1  8 
14:1 
14:1  i0 
14:1  6 
I0:I  8 
I:I 
I0:I  9 
i:I 
lO:l 
I0:I  19 
I0:I  I0 
6 
6 
--  6 
--  7 
8 
--  8 
--  11 
N  11 
--  8 
8 
7 
--  9 
10:1  9 
Result 
$ 
days 
Not infected 
g¢  ¢¢ 
9  Poliomyelitis 
Not infected 
--  Not infected 
9  Poliomyelitis 
Not infected 
15  Poliomyelitis 
14  " 
10  " 
Not infected 
12  Poliomyelitis 
Not infected 
11  Infected, killed 
14  Poliomyelitis 
14 
7 
9 
11  Infected, killed 
Lived,  paralyzed 
9  Poliomyelitis 
9 
10 
10 
11 
effect a  neutralization in a  ratio  of 1:10,  but  usually  fail  in  1:15. 
According to our observations four out of nine were effective in 1:10. 
This knowledge is of practical value in that it is not necessary to 
search for convalescent cases for a supply of effective serum. 556  ANTIPOLIOMYELITIC HORSE  SERUM  CONCENTRATE 
TABLE  II 
Progress of Horse 4 
"0 
f.,C. 
250  0.4 
30  0.4 
79  0.4 
214  0.4 
34  0.4 
253  D.4 
254  0.4 
228  [).4 
259  9.3 
268  9.4 
269  9.4 
152  ~.3 
~51  9.15 
314  9.4 
H5  9.4 
316  3.4 
317  3.4 
HI  0.3 
H2  0.15 
.~85  0.4 
~29  3.4 
~28  0.4 
H5  0.4 
H4  3.3 
$17  0.15 
327  3.3 
313  1o.15 
330  3.4 
335  ~).3 
336  ~). 15 
d 
Serum  tested 
145~  ~ Poliomyelitis,  Horse  4,  initial 
145i J  bleeding, 9/13/27 
145 
145 
145  Poliomyelitis, Horse 4, bleeding 
145  of 1/14/29 
145 
145  Control 
145  " 
248 ~  Poliomyelitis, Horse 4, bleeding 
248 f  of 2/21/29 
248  Control 
248  " 
298 ~  Poliomyelitis, Horse 4, bleeding 
298 f  of 3/20/29 
298 ~  Poliomyelitis, Horse 4, bleeding 
298 f  of 5/8/29 
298  Control 
298  " 
284 
285  Poliomyelitis, Horse 4, bleeding 
320  of 7/5/29 
320 
320  Control 
320  " 
284  " 
284  " 
285  Poliomyelitis, Horse 4,  bleeding 
of 8/26/29 
285  Control 
285  " 
"~ 
days  days 
5:1  7  7 
10:1  7  8 
20:1  7  8 
10:1  -- 
20:1  9 
20:1i  20 
25:1  14 
--  7 
4 
20:1  9 
25:1  7 
7 
9 
20:1 
10:1 
20:1  17 
10:1 
6 
6 
66:1  9 
50:1  13 
20:1  -- 
10:1  -- 
7 
6 
--  6 
--  6 
25:1  -- 
m  8 
--  7 
10 
23 
16 
9 
4 
10 
8 
10 
10 
21 
14 
14 
10 
15 
13 
19 
6 
6 
11 
Killed 
Result 
Poliomyelitis 
¢¢ 
c¢ 
Remained well 
Poliomyelitis 
lc 
Remained well 
Poliomyelitis 
Remained well 
Poliomyelitis 
g¢ 
¢¢ 
Remained well 
Poliomyelitis 
4¢ 
Remained well 
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TABLE  HI 
Serum Preparations from Horse 4 Refined by Ban~.kaf 
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275 
276 
313 
308 
321 
322 
323 
345 
330 
357 
336 
334 
365 
398 
367 
368 
444 
443 
277 
31t 
312 
314 
317 
354 
355 
356 
417 
418 
376 
377 
385 
442 
Serum tested 
Globulin  preparation 1 
a*  ~  5 
a*  **  6 
¢c  c~  6 
ca  ~  7 
"  "  7 
~  ~  7 
~  ~  7 
Control 
~C 
C~ 
Normal horse serum Control A 
"  "  "  "  B 
~  ~  ~  ~C  C 
Result 
Poliomyelitis 
Remained well 
Poliomyelitis 
Remained well 
Poliomyelitis 
C¢ 
Remained well 
Poliomyelitis 
Remained well 
*c  C* 
Poliomyelitis 
*C 
~C 
The Results of Immunization 
Referring now to the horses, the first animal, Horse 4, had previously 
been injected subcutaneously by one of us (Banzhaf) over a period of 558  ANTIPOLIOMYELITIC  HORSE SERU'~  CONCENTRATE 
16 months with virus of very dubious potency.  Bleedings, during and 
subsequent to this treatment failed to show any specific antibody. 
The inoculations with emulsions of known virulence, were resumed 
in October, 1928, this time intravenously.  This work was begun on a 
more  elaborate  scale  because  of  the  fund  given  by  Mr.  Jeremiah 
OCt.  No~.  Dec.  Jan.  Feb Na~ 
1:100 
,1:90 
1:80 
1:70 
1:5o 
1:3o  • 
1:20  ,~  ....  ~ ~,  ~/,  /,  ~  • 
1:10  i  ~-/ 
0..  ~  ° 
AntiDOdYvoiume  loss.  tl~vou~,  concentration,  is  5b,out  ~ 
Concentration  o  r  P/ABI'IA,  (Isolation  c~  GLOBULIN) 
CHA~T  1 
Milbank.  Encouraging results were obtained and in  the following 
January the serum was capable of neutralization in the ratio of 10:1. 
The titre continued to mount and bulk bleedings were made from time 
to time when late in the summer the animal died from an obscure in- 
fection which resulted in the death of several other horses in the same 
stable.  A preliminary report dealing with the successful immunization F..  R.  WEYER,  W.  H.  PARK,  AND  F..  ~.  BANZHAF  559 
of this horse was presented by Park before the American Association 
of Pathologists and Bacteriologists at Chicago, March 28th, 1929 (8, 9). 
The larger bleedings from this horse were drawn into citrate solution 
and concentrations were made according to the following scheme: 
The method of fractional concentration of antisera  with ammonium sulfate 
(Banzhaf (9)), without the heating process, is followed.  We have not up to the 
present time detemined the heat resisting point of the neutralizing antisubstances. 
After the method mentioned has been carried through to dialyzing free from salts, 
it will be noted that some precipitation has formed which contains some of the anti- 
substances.  A gentle rotation of the concentrated fluid in the dialyzing bags will 
resuspend the precipitate.  The fluid is measured and three volumes of distilled 
water added.  Sufficient sodium chloride is added to bring the whole to one- 
twentieth normal (50 cc. normal sodium chloride per litre) and  adjusted to pH 
5.0-5.1 and placed into a cold room 5-10°C. overnight.  The resulting precipitate 
consists of further inert substances  and practically all the chill producing  sub- 
stances usually present in all sera.  These substances  are removed by filtration 
through paper pulp.  The clear filtrate adjusted to pH 6.8 and allowed to stand 
overnight for a further inert fibrin like precipitate which may form, if present it is 
removed by filtration.  To the clear filtrate a half volume of saturated ammonium 
sulfate solution is added to reprecipitate the globulins and antisubstances.  The 
precipitate is recovered by filtration, pressed free from fluid and dialyzed free from 
salts.  To the dialyzed concentrated fluid 1 per cent sodium chloride and 0.5 per 
cent phenol are added, it is clarified by filtering through paper pulp and passed 
through a Berkefeld filter to sterilize. 
Referring to Chart 1, it will be seen that the increase in globulin con- 
centration  from  this  procedure  is  three  to  four-fold  aud  that  the 
preparation of maximum potency is approximately five times as potent 
as average human convalescent serum. 
Following the loss of Horse 4, immunization was commenced upon 
two other horses, Nos. 5 and 6.  The jugular vein was selected as the 
route of injection in view of the success obtained by that method in 
Horse 4.  Neither horse had any demonstrable "native" antibody to 
begin with, nor was any acquired though they received the total sub- 
stance of approximately 25  virulent spinal  cords and brains  over a 
period  of a  year.  During  this  period  the  route  of inoculation was 
varied and the sequence of injection changed but with the appearance 
of no  neutralizing value,  even  in  a  ratio  of  1:1,  these  horses  were 
abandoned in May, 1930. 560  ANTIPOLIOMYELITIC  HORSE  SERU'rvr  CONCENTRATE 
TABLE  IV 
Protocols of Horses 5 and 6, Failure to Respond 
Monkey  ~ 
No.  .~ 
4/2/29 
265 
263 
5/13/29 
281 
286 
288 
289 
6/27/29 
318 
319 
320 
7/17/29 
324 
325 
314 
317 
8/21/29 
323 
326 
310 
9/9/29 
321 
315 
327 
313 
11/11/29 
364 
366 
2/11/30 
377 
376 
417 
418 
5/20/30 
368 
Serum tested 
0.4  277  Horse 5, initial bleeding 
0.4  277  "  6,  "  " 
0.4  267  "  5, bled 5/7 
0.4  267  "  5,  "  5/7 
0.4  267  "  6,  "  5/7 
0.4  267  "  6,  "  5/7 
0.4  298  "  5,  "  6/24 
0.4  298  "  6,  "  6/24 
0.3  298  Control 
0.4  320  Home 5, bled 7/15 
0.4  320  "  6,  "  7/15 
0.3  320  Control 
0.15  320  " 
0.4  314  Horse 5, bled 8/21 
0.4  314  "  6,  "  8/21 
0.15  314  Control 
0.6  267  Horse 5, bled 9/9/29 
0.6  267  "  6,  "  9/9/29 
0.3  267  Control 
0.15  267  " 
0.6  285  Horse  5,  -b  Horse  6,  bled 
11/13/30 
0.3  285  Control 
0.3  402  Horse 5, bled 2/11/30 
0.3  402  "  6,  "  2/11/30 
0.3  402  Control 
O. 1  402  " 
0.5  445  Horse 5, bled 5/20/30 
o  m  -~ ~  ~  Result 
days  days 
5:1  7  10  Poliomyelltis 
5:1  7  10  " 
20:1  7  8  " 
10:1  7  8  " 
20:1  5  7  " 
10:1  9  10  " 
5:1  10  17  " 
5:1  11  18  " 
--  8  11  " 
5:1  7  9  " 
5:1  12  17  " 
--  7  13  " 
--  6  19  " 
2.5:1  8  11  " 
2.5:1  8  11  " 
--  8  11  " 
1:1  7  10  " 
1:1  6  10  " 
--  6  6  " 
--  6  6  " 
1:1  8  9  " 
--  6  6  " 
1:1  9  9  " 
1:1  9  10 
--  7  7  " 
--  7  10  " 
2.5:1  7  11  " E. R. V/EYER, W.  H. PARK, AND E. J. BANZIIAF  561 
Two more horses were started,  June,  1930.  The injections were 
given intradermally in one case and subcutaneously in the other.  As 
will be seen from the protocols, antibody content of the serums rose 
from an apparent zero value to the vicinity of 25.1 in 5 months in each 
case. 
TABLE  V 
~"  ~ ¥  i  Serum~ted  o  ~.s  ~  ~o 
¢.G, 
0.5  402  Horse 7, serum before treatment  1:1 
0.3  402  Control 
0.I  402 
0.5  4451  Horse 7, after 7 wks.  2.5:1 
0.15  44.:  Control 
0.05  44~  " 
0.4  f  Horse 7, after 11 wks.  5:1 
0.4  g  "  7,  "  11  "  10:1 
0.3  9  Control 
O. 15  9  " 
0.5  9  Horse 7, after 17 wks.  20:1 
0.15  9  Control 
D.4  457  Horse 7, after 25 wks.  30:1 
C).3  457  Control 
D. 15  457  " 
~. 4  9  Horse 8, before treatment  1 : 1 
O. 3  9  Control 
0.15  9  " 
0.5  9  Horse 8, bled after 9 wks.  5:1 
0.5  9  "  8,  "  "  9  "  20:1 
0.15  9  Control 
0.4  10  Horse 8, after 9 wks.  30:1 
0.3  10  Control 
0.15  i0  " 
days !days 
10  13 
7  7 
7  10 
6  6 
7  11 
10  12 
10  12 
11  14 
9  11 
11  40 
11  23 
7  12 
10  12 
10  12 
11  14 
9  17 
8  11 
8  40 
Result 
Poliomyelitis 
No infection 
PoliomyeUtis 
No infection 
Poliomyelitis 
No infection 
Poliomyelitis 
tg 
tt 
tt 
No Mection 
Poliomyelitis 
ili 
In the case of these two animals, over a portion of the immunizing 
period, 0.1  per cent of alum was incorporated in  the  saline  used  in 
preparing the emulsions. 
Again, in May, 1930,  three additional horses were put on the im- 
munizing treatment.  By August, two of these horses were found to 
have  responded.  The  injections were given  subcutaneously, intra- 562  ANTIPOLIOMYELITIC HORSE  SERLr~  CONCENTRATE 
muscularly and intravenously in each animal.  The third horse failed 
to respond satisfactorily and was discarded.  Concentrated prepara- 
tions from the two producing animals showed complete neutralizatiou 
in 100:1 or better. 
That the mechanism of virus neutralization by the horse serums 
might  be  explained  by  some  non-specific  phenomenon  has  been 
advanced.  It is true that the immunization treatment brings forth a 
decided response with respect to the nerve tissue necessarily contained 
in the inoculum.  This is readily demonstrated by complement fixation 
or simple flocculation procedures.  However, it is hardly conceivable 
that this flocculation of emulsified cord by the antiserum could inacti- 
vate the virus by entrainment or otherwise in view of proof that serum 
preparations are still potent after removal therefrom of the antinerve 
tissue bodies by absorption.  A monkey was  intracranially injected 
with an incubated mixture composed of virulent cord emulsion and a 
serum preparation which had previously been incubated for 2 hours with 
a heavy (20 per cent) emulsion of normal monkey cord and subsequent 
centrifugalization.  Furthermore, horses which have made no  anti- 
virus response have acquired anticord properties. 
Pettit (6) and others have advocated that in the absence of suitable 
antipoliomyelitis serum other serums or indeed any protein substance, 
e.g.  milk, may be used intraspinally with amelioration of symptoms 
effected by the non-specific protein shock resulting therefrom.  Our 
results gleaned from the treatment of infected monkeys tend to  indi- 
cate that the chance for recovery is in direct ratio to the virucidal 
potency of the serum used.  In addition, the results obtained when 
the serum preparations were used intraspinally were far better  than 
similar treatment introduced through any other route, even though 
the amount of serum injected were 3 to 5 times as much.  If the spinal 
cord is chosen as the most advantageous route for treatment, it follows 
that concentration of antibodies is of prime importance in view of the 
limited capacity of the canal.  (1 to 2 cc. in small monkeys and 5 to 
20 cc. in children.) 
Having acquired a particularly potent strain of monkey virus which 
proved sufficiently invasive to produce typical poliomyelitis when the 
emulsion was dropped into the noses of the monkeys on 3 successive 
days, experiments represented in the following charts were conducted, E.  R.  WEYER,  ¢W.  H.  PARK,  AND  E.  ].  BANZH.A]~  563 
with a view to the determination of the relative merits of human con- 
valescent serum and the concentrated horse product when used intra- 
venously and intraspinally.  The virus is  doubtless transmitted by 
way of the nasal mucosa in human contacts so these results should 
prove of some value from the standpoint of human therapeutics.  So 
TABLE  VI 
t48  O. 5  445 
t40  0.4  9 
t41  0.4  9 
854  D.15  445 
852  0.05  445 
148  0.4  9 
375  ~.3  9 
813  0.1  9 
i71  0.4  10 
~74  0.4  487 
~75  0.3  10 
~58  0.15  10 
~94  0.3  487 
i95  0.15  487 
~51  0.5  445 
~54  0.15  445 
i52  0.05  445 
~39  0.5 
t39  0.4 
14)3  0.15 
163  0.15 
~13  0.1 
Serum tested  ~  Result 
days  d~y~ 
Horse 9, after 12 wks.  2.5:1  --  --  No infection 
"  9,  "  12  "  5:1  "  " 
"  9,  "  12  "  10:1  "  " 
Control  --  6  6  Poliomyelitis 
"  --  7  11  " 
Horse 9, after 20 wks.  20:1  10  20  'L 
Control  --  10  11  "  --killed 
"  --  12  15  "  " 
Horse 9, after 32 wks.  20:1  No infection 
"  9,  "  32  "  25:1  "  " 
Control  --  8  11  Poliomyelitis 
"  --  8  40  " 
"  --  7  7  " 
"  --  9  9  " 
Horse 10, after 10wks.  2.5:1  7  11  " 
Control  --  6  6  " 
"  --  7  11  " 
Horse 10, after 18 wks.  2.5:1  --  .  --  No infection 
"  I0,  "  18  "  I0:I  8  14  Poliomyelitis 
Control  --  11  14  " 
"  --  11  14  " 
"  --  12  15  " 
far,  we have not  found curative measures to be effective when the 
monkey is inoculated intracraniaUy. 
These data were presented by Weyer in a preliminary report read 
before the American Association of Immunologists on April 16th, 1930, 
and confirmation of the results with our serum concentrates has been 
more recently  presented by Rhoads (10). 564  ANTIPOLIOM~YELITIC  HORSE  SEl~D-~  CONCENTRATE 
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The results indicated in Chart  2 tend to show that  the horse anti- 
body preparations  are  more  effective when  used  intraspinally  than 
even greater amounts directed into the blood stream.  Four monkeys 
out of six, treated intravenously survived as contrasted with the eight 
animals  out  of  nine  which  failed  to  come  down  after  intraspinous 
treatment even though instituted later in two cases. 
One intrasplnous injection is apparently as effective as two; material 
removed on the 2nd day after an injection is similar in physical proper- 
ties at least to the injected globulin preparation. 
I wk.l~r  8wlt~  3~.  4wl~  5~  6~1~ 
convalescent 
428  20cc. humo~  eee 
convalescent  myeaitis 
419  , ~lobulin  •  •  • 
420  10cc  hot~e 
~lobulin  •  •  •  ~ur~iv~) 
411  5cc. horse  ~tobalin  •  •  •  3utwi~d) 
403  lcc. ho~e  Oied,  poli~ 
~lobulin  •  •  •  myeliti~ 
424  Contt~ol  •  •  •  Died,  polio 
myelitis 
C~T  3 
The fact that  four out of five of the animals  treated  with human 
convalescent serum died may be attributed  to the fact that  the anti- 
body  concentration  was  not  sufficient  to  prevent  extension  of  the 
infection. 
Observati~s on Prophylaxis 
The value of the serum as a preventative can only be judged by the 
results of the few experiments shown in tabular form.  10 cc. of the 
globulin concentrate from an immunized horse was apparently respon- 
sible  for  protection  over  a  period  of  at  least  5  weeks.  Twice  the 
amount of human convalescent serum failed to protect for 3 weeks. 566  ANTIPOLIOMYELITIC  HORSE SERUM CONCENTRATE 
The results from these experiments cause us to consider at once the 
possibility of utilizing an antipoliomyelitis preparation for the purpose 
of protecting children in a  family where a  case of poliomyelitis has 
been reported.  The administration of serum would probably be of 
more worth from the psychological point of view in allaying the fears 
of parents.  Statistics would indicate that a second case in one family 
in  interepidemic times is  even rarer than  the normal incidence for 
poliomyelitis in  general.  Flexner has already suggested  the  advis- 
ability of thus using convalescent serum. 
More recently, Fairbrother  (11),  also aided by the Jeremiah Mil- 
bank gift has obtained an antipoliomyelitic horse serum which, sub- 
sequently, yielded a potent product. 
SUMMARY 
1.  The horse, apparently itself unsusceptible to poliomyelitis, can 
be stimulated in certain cases but not all to the production of virucidal 
antibodies. 
2.  The virucidal potency of such immune serum' can be raised to a 
point  comparable  to  that  of human  convalescent serum  and when 
concentrated and refined exhibits a four-fold increase in potency. 
3,  Such  concentrates have  proved  effective in  the  prevention  of 
paralysis in inoculated monkeys when given intraspinously before the 
onset of paralysis. 
4.  Treatment  has  been  found  more  effective  when  therapeutic 
serums are given through the spinal route. 
5.  Pooled serum from "normal" adult donors has proved effective 
in neutralizing virus but its potency is approximately one-half that of 
convalescent serum. 
BIBLIOGRAPHY 
1.  Netter, A., Bull. Acad. m~d., Paris, 1915, 74, 3,403. 
2. Levaditi, C., and Landsteiner, C., Compt. rend. Soc. biol., 1910, 68, 311. 
3.  Aycock, W. L., and Kagan, J. R., J. Iramunol., 1927, 14, 85. 
4.  Flexner, S., d. Am. Med. Assn., 1910, 55, 1105. 
5. Neustaedter, M., and Banzhaf, E. S., ]. Am. Med. Assn., 1917, 68, 1531. 
6.  Pettit, A., Compt. rend. Soc. biol., 1918, 81, 1087. 
7.  Stewart, F., and Haselbauer, P., J. Exp. Med., 1928, 48, 449. 
8.  Weyer, E. R., Park, W. H., and Banzhaf, E. J., Am. J. Path., t929, 51 517. 
9.  Coll. Studies Bureau Lab., Dept. Health, New York, 1912-1913, 7, 115. 
10. Rhoads, C. P., Y. Exp. Med., 1931, 53, 123. 
11. Fairbrother, R. W., Brit. J. Exp. Path., 1930, 11, 43. 